Impact of the COVID-19 Pandemic on the Provision of Dialysis Service and Mortality in Veterans Receiving Maintenance Hemodialysis in the VA: An Interrupted Time-Series Analysis

Author:

Patel Samir,Trujillo Rivera Eduardo A.,Raman Venkatesh K.,Faselis Charles,Wang Virginia,Fink Jeffrey C.,Roseman Jeffrey M.,Morgan Charity J.,Zhang Sijian,Sheriff Helen M.,Heimall Michael S.,Wu Wen-Chih,Zeng-Treitler Qing,Ahmed Ali

Abstract

<b><i>Introduction:</i></b> According to the US Renal Data System (USRDS), patients with end-stage kidney disease (ESKD) on maintenance dialysis had higher mortality during early COVID-19 pandemic. Less is known about the effect of the pandemic on the delivery of outpatient maintenance hemodialysis and its impact on death. We examined the effect of pandemic-related disruption on the delivery of dialysis treatment and mortality in patients with ESKD receiving maintenance hemodialysis in the Veterans Health Administration (VHA) facilities, the largest integrated national healthcare system in the USA. <b><i>Methods:</i></b> Using national VHA electronic health records data, we identified 7,302 Veterans with ESKD who received outpatient maintenance hemodialysis in VHA healthcare facilities during the COVID-19 pandemic (February 1, 2020, to December 31, 2021). We estimated the average change in the number of hemodialysis treatments received and deaths per 1,000 patients per month during the pandemic by conducting interrupted time-series analyses. We used seasonal autoregressive moving average (SARMA) models, in which February 2020 was used as the conditional intercept and months thereafter as conditional slope. The models were adjusted for seasonal variations and trends in rates during the pre-pandemic period (January 1, 2007, to January 31, 2020). <b><i>Results:</i></b> The number (95% CI) of hemodialysis treatments received per 1,000 patients per month during the pre-pandemic and pandemic periods were 12,670 (12,525–12,796) and 12,865 (12,729–13,002), respectively. Respective all-cause mortality rates (95% CI) were 17.1 (16.7–17.5) and 19.6 (18.5–20.7) per 1,000 patients per month. Findings from SARMA models demonstrate that there was no reduction in the dialysis treatments delivered during the pandemic (rate ratio: 0.999; 95% CI: 0.998–1.001), but there was a 2.3% (95% CI: 1.5–3.1%) increase in mortality. During the pandemic, the non-COVID hospitalization rate was 146 (95% CI: 143–149) per 1,000 patients per month, which was lower than the pre-pandemic rate of 175 (95% CI: 173–176). In contrast, there was evidence of higher use of telephone encounters during the pandemic (3,023; 95% CI: 2,957–3,089), compared with the pre-pandemic rate (1,282; 95% CI: 1,241–1,324). <b><i>Conclusions:</i></b> We found no evidence that there was a disruption in the delivery of outpatient maintenance hemodialysis treatment in VHA facilities during the COVID-19 pandemic and that the modest rise in deaths during the pandemic is unlikely to be due to missed dialysis.

Publisher

S. Karger AG

Subject

Nephrology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3